Inhibikase Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
IKT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3350 Riverwood Parkway Se, Suite 1900, Atlanta, GA

There are no Buy or Sell transactions made by insiders since 10/5/2023

Inhibikase Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Frattaroli Cheif Financial Officer $38.5K Mar 1, 2023
Paul C. Grint Director Jul 16, 2024
Dennis N. Berman Director Jul 16, 2024
Milton H. Werner President and CEO, Director, 10%+ Owner Apr 1, 2024
Roy Lester Freeman Director Jul 16, 2024
Gisele Dion Director Jul 16, 2024
Garth Lees-Rolfe Chief Financial Officer Apr 1, 2024
Elizabeth G. O'Farrell Director Jun 24, 2022

Recent Insider Transactions by Companies or Individuals for Inhibikase Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.